[go: up one dir, main page]

FR2357250A1 - TOPICAL ANTIMYCOSIC COMPOSITION CONTAINING AN IMIDAZOLYL-PHENOXYPHENYL-PYRIDINYL-PHENYLMETHANE - Google Patents

TOPICAL ANTIMYCOSIC COMPOSITION CONTAINING AN IMIDAZOLYL-PHENOXYPHENYL-PYRIDINYL-PHENYLMETHANE

Info

Publication number
FR2357250A1
FR2357250A1 FR7720666A FR7720666A FR2357250A1 FR 2357250 A1 FR2357250 A1 FR 2357250A1 FR 7720666 A FR7720666 A FR 7720666A FR 7720666 A FR7720666 A FR 7720666A FR 2357250 A1 FR2357250 A1 FR 2357250A1
Authority
FR
France
Prior art keywords
phenylmethane
phenoxyphenyl
antimycosic
pyridinyl
imidazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7720666A
Other languages
French (fr)
Other versions
FR2357250B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2630252A external-priority patent/DE2630252C3/en
Priority claimed from DE19772709964 external-priority patent/DE2709964A1/en
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2357250A1 publication Critical patent/FR2357250A1/en
Application granted granted Critical
Publication of FR2357250B1 publication Critical patent/FR2357250B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Composition antimycosique. La composition de l'invention contient de l'imidazol-1-yl-(4-phénoxyphényl) - (pyridin-2-yl)-phénylméthane en association avec un excipient inerte non toxique, acceptable du point de vue pharmaceutique. Application locale pour le traitement de mycoses en médecine humaine et en médecine vétérinaire.Antimycotic composition. The composition of the invention contains imidazol-1-yl- (4-phenoxyphenyl) - (pyridin-2-yl) -phenylmethane in association with an inert, non-toxic, pharmaceutically acceptable excipient. Local application for the treatment of mycoses in human medicine and veterinary medicine.

FR7720666A 1976-07-06 1977-07-05 TOPICAL ANTIMYCOSIC COMPOSITION CONTAINING AN IMIDAZOLYL-PHENOXYPHENYL-PYRIDINYL-PHENYLMETHANE Granted FR2357250A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2630252A DE2630252C3 (en) 1976-07-06 1976-07-06 Use of imidazol-1-yl- (4-phenoxyphenyl) - (pyridin-2-yl) phenylmethane in the local control of dermatomycoses
DE19772709964 DE2709964A1 (en) 1977-03-08 1977-03-08 Long lasting topical antimycotic compsns. - contg. imidazolyl phenoxyphenyl phenyl pyridinyl methane

Publications (2)

Publication Number Publication Date
FR2357250A1 true FR2357250A1 (en) 1978-02-03
FR2357250B1 FR2357250B1 (en) 1980-06-27

Family

ID=25770663

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720666A Granted FR2357250A1 (en) 1976-07-06 1977-07-05 TOPICAL ANTIMYCOSIC COMPOSITION CONTAINING AN IMIDAZOLYL-PHENOXYPHENYL-PYRIDINYL-PHENYLMETHANE

Country Status (6)

Country Link
US (1) US4141981A (en)
JP (1) JPS536426A (en)
AU (1) AU511410B2 (en)
FR (1) FR2357250A1 (en)
IL (1) IL52448A (en)
NZ (1) NZ184548A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
CN101287411B (en) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 Drug Information System and Its Use
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK3395372T3 (en) 2009-02-20 2022-04-19 Enhanx Biopharm Inc Glutathione-based drug delivery system
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103254136B (en) * 2013-05-30 2015-03-25 苏州大学 Method for preparing quadri [4-(1- imidazolyl) phenyl] methane

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092026A1 (en) * 1970-04-09 1972-01-21 Bayer Ag

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009020C3 (en) * 1970-02-26 1979-09-13 Bayer Ag, 5090 Leverkusen Process for the preparation of N- (l, l, l-trisubstituted) -methylazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092026A1 (en) * 1970-04-09 1972-01-21 Bayer Ag

Also Published As

Publication number Publication date
AU511410B2 (en) 1980-08-21
AU2678777A (en) 1979-01-11
NZ184548A (en) 1981-10-19
JPS536426A (en) 1978-01-20
FR2357250B1 (en) 1980-06-27
US4141981A (en) 1979-02-27
IL52448A0 (en) 1977-10-31
IL52448A (en) 1981-09-13

Similar Documents

Publication Publication Date Title
ATE125445T1 (en) ORAL COMPOSITION FOR THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES.
BE873973A (en) METRONIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING
NO1994018I1 (en) Mometasone furoate
FR2357250A1 (en) TOPICAL ANTIMYCOSIC COMPOSITION CONTAINING AN IMIDAZOLYL-PHENOXYPHENYL-PYRIDINYL-PHENYLMETHANE
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
EP0270690A4 (en) MEDICINE FOR THE TREATMENT AND PROPHYLAXIS OF KIDNEY AND LIVER DISEASES.
BE837662A (en) GELIFIED COMPOSITION CONTAINING TRETINOINE FOR THE TREATMENT OF ACNE
FR2510889B1 (en) MEDICINE CONTAINING CERTAIN RIBOFURANNOSYL-3 ', 5'-CYCLIC PHOSPHATES SUBSTITUTED IN 6, 8 FOR THE TREATMENT OF PROLIFERATIVE SKIN DISEASES
JPS5218813A (en) Plasters for the relief of cutaneous diseases
BE761444A (en) NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MICROBIAL INFECTIONS
NL7609559A (en) PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND MEDICINAL AGENTS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
FR2358893A1 (en) ANTIMICROBIAL COMPOSITION CONTAINING 1-IMIDAZOLYL-BUTANE-2-ONES OR -BUTANE-2-OLS HALOGENES
FR2310769A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA
IL52718A0 (en) Method and compositions for treatment and prophylaxis of helminth infections in animals comprising diamphenethide together with oxfendazole
ATE22282T1 (en) PENTACYCLOUNDECAN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2311553A1 (en) MEDICINE FOR THE TREATMENT OF SCHIZOPHRENIA
BE860992A (en) COMPOSITION AND BUFFER FOR THE TREATMENT OR PREVENTION OF ACNE AND SIMILAR SKIN DISORDERS
FR1323056A (en) Method and composition for coating pharmaceutical tablets
FR2048M (en) Therapeutic agent containing solubilized hydrocortisone acetate for the treatment of inflammatory diseases.
ATE41604T1 (en) MEDICINAL PRODUCT FOR ORAL ADMINISTRATION, CONSISTING ON THE ONE HAND OF 9-ALPHA,11-BETA-DICHLORO-16-ALPHAMETHYL-21-OXYCARBONYLDICYCLOHEXYL-METHYLOXYPREGNA-1,4-DIENE-3,20-DIONE AS AN ACTIVE SUBSTANCE AND ON THE OTHER HAND OF AN INERT PHARMACEUTICAL EXIPIENTS S, THAT THE EFFECTIVENESS OF THE PRODUCT TO EXPRESS IN THE RECTUM OR IN THE COLON AND THE USE OF THIS SUBSTANCE FOR
BE605476A (en) Veterinary composition for the treatment of enterohepatitis in turkeys
FR2014M (en) Medicament for the treatment of eczema and other skin diseases, in particular conditions causing baldness.
FR2732M (en) Drug composition, in particular for dietetics and the treatment of gastrointestinal complaints.
ATE36333T1 (en) HYDANTOIN CONTAINING THERAPEUTIC AGENT.
BE892781A (en) NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES

Legal Events

Date Code Title Description
ST Notification of lapse